How Long Is Cagrilintide Stable Once Reconstituted?

Most peptide failures don't happen at the injection stage. They happen during storage. Cagrilintide, like all dual GIP/GLP-1 receptor agonists, loses potency fast once mixed with bacteriostatic water, and there's no visual way to detect it. A vial that looks perfectly clear can be completely inactive if it's been stored incorrectly for even a few hours.

Our team has worked with hundreds of researchers using peptides in metabolic studies. The most common mistake isn't contamination or injection technique. It's assuming that reconstituted peptides behave like lyophilised powders. They don't.

How long is cagrilintide stable once reconstituted?

Cagrilintide remains stable for 28 days after reconstitution when stored at 2–8°C (refrigerated). Beyond 28 days, peptide degradation accelerates regardless of storage conditions. Temperature excursions above 8°C cause irreversible protein denaturation that neither visual inspection nor potency testing at the lab bench can detect reliably.

The 28-day stability window isn't a conservative estimate. It's backed by accelerated degradation studies published in peptide chemistry journals. Cagrilintide contains 45 amino acids in a specific three-dimensional configuration. Once that structure denatures, the peptide no longer binds to GIP or GLP-1 receptors with therapeutic affinity. You're injecting an inactive compound.

This article covers the exact mechanism behind cagrilintide degradation, what temperature ranges preserve vs destroy potency, and the storage protocols that matter when your study timeline depends on consistent dosing.

Why Cagrilintide Degrades Faster Than Expected

Cagrilintide is a long-acting dual agonist. Meaning it binds to both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism requires a complex tertiary structure stabilised by disulfide bridges and hydrogen bonds. Once reconstituted with bacteriostatic water, those bonds become vulnerable to hydrolysis. The process where water molecules break peptide bonds over time.

Hydrolysis accelerates exponentially with temperature. At 25°C (room temperature), hydrolysis rates can triple compared to refrigerated storage. A single overnight temperature excursion. Like leaving a vial on the lab bench. Can reduce potency by 15–30% within 12 hours. That's not detectable by eye. The solution stays clear. The pH doesn't shift noticeably. But the peptide's binding affinity drops below therapeutic thresholds.

Bacteriostatic water extends stability slightly by preventing microbial growth, but it doesn't stop chemical degradation. The benzyl alcohol in bacteriostatic water (typically 0.9%) preserves sterility. Not peptide structure. Once you mix lyophilised cagrilintide with any aqueous solution, the clock starts. We've seen research groups lose entire study cohorts because reconstituted peptides sat in a malfunctioning mini-fridge that cycled between 4°C and 12°C.

The 28-day stability window applies only when refrigeration is uninterrupted. If your storage unit has daily temperature fluctuations above 8°C, the effective stability window drops to 14–21 days. Real Peptides sources every compound with exact amino-acid sequencing and provides full reconstitution protocols. But even high-purity peptides can't overcome poor storage.

Temperature Thresholds That Define Potency Loss

Cagrilintide stability is binary below and above specific temperature thresholds. Between 2–8°C, degradation rates remain under 5% per month. Between 8–15°C, degradation accelerates to 10–20% per month. Above 15°C, you're looking at 30–50% potency loss within two weeks.

These aren't approximate ranges. They're derived from accelerated stability studies where peptide samples are incubated at controlled temperatures and tested via HPLC (high-performance liquid chromatography) for intact peptide concentration. The degradation curve is logarithmic, not linear. That means most of the damage happens in the first few days after a temperature spike, not gradually over weeks.

Freezing reconstituted cagrilintide (storing it at −20°C) doesn't extend stability the way it does for lyophilised powder. Ice crystal formation physically disrupts peptide structure. When you thaw it, the peptide may look fine, but binding assays consistently show reduced receptor affinity. Some labs try aliquoting reconstituted peptides into single-use vials and freezing them to avoid repeated freeze-thaw cycles. But even a single freeze event damages tertiary structure irreversibly.

If you're transporting reconstituted cagrilintide, use a validated cold chain container that maintains 2–8°C for the entire transit period. Gel packs aren't sufficient unless you're travelling less than six hours. Purpose-built peptide coolers with temperature loggers are the standard in pharmaceutical transport. We've guided researchers through peptide transport protocols where even a 30-minute delay at airport security caused measurable potency loss.

The bottom line: if your refrigerator doesn't have a continuous temperature monitor, you don't actually know if your peptides stayed stable. A digital thermometer that logs min/max temps costs less than replacing one degraded vial.

Storage Protocols That Preserve Research-Grade Peptides

Reconstituted cagrilintide must be stored in a dedicated pharmaceutical-grade refrigerator. Not a standard lab fridge that gets opened 20 times per day. Every door opening causes a temperature spike. Standard lab refrigerators fluctuate ±3°C during normal use. That's enough to shorten the 28-day stability window to 18–21 days.

Store vials in the centre of the fridge, not on the door or near the back wall where temperature cycling is most pronounced. Use amber glass vials or wrap clear vials in aluminium foil. Light exposure degrades peptides through photo-oxidation. Cagrilintide is particularly sensitive to UV and blue light wavelengths, which break down aromatic amino acids like tryptophan and tyrosine in the peptide chain.

Label every vial with the reconstitution date, not the expiration date. The 28-day countdown starts the moment bacteriostatic water touches the lyophilised powder. If you reconstituted a vial on March 1st, it's expired by March 29th. Even if the original powder had a two-year shelf life. We've seen labs lose track of reconstitution dates and use peptides that had been sitting for six weeks. The study data was worthless.

Never store reconstituted peptides in the same fridge as volatile solvents or strong acids. Vapour contamination is real. Benzyl alcohol vapour can migrate through micro-perforations in rubber stoppers over time, and even trace solvent exposure alters peptide behaviour in downstream assays.

If you're working with Real Peptides, every vial ships with storage guidelines specific to the compound's molecular structure. Those aren't generic recommendations. They're tailored to the exact peptide sequence and formulation method used in synthesis.

Cagrilintide Stability: Storage Condition Comparison

Key Takeaways

• Cagrilintide remains stable for exactly 28 days post-reconstitution when refrigerated continuously at 2–8°C. This is not a conservative estimate but a hard degradation threshold.
• Temperature excursions above 8°C cause exponential hydrolysis rates, reducing potency by 15–30% within 12 hours even if the solution appears visually unchanged.
• Freezing reconstituted cagrilintide (−20°C) damages the peptide's three-dimensional structure through ice crystal formation. Thawed peptides show reduced receptor binding affinity regardless of visual clarity.
• Standard lab refrigerators with frequent door openings create ±3°C temperature fluctuations that shorten the effective stability window to 18–21 days.
• Light exposure degrades aromatic amino acids in cagrilintide through photo-oxidation. Store all reconstituted peptides in amber glass vials or wrap clear vials in aluminium foil.
• Bacteriostatic water prevents microbial contamination but does not slow peptide degradation. The 28-day clock starts the moment water contacts lyophilised powder.

What If: Cagrilintide Storage Scenarios

What If I Left Reconstituted Cagrilintide Out Overnight?

Discard it. A vial left at room temperature (20–25°C) for 8–12 hours has lost 20–40% potency through hydrolysis and oxidation. There's no visual indicator. The solution stays clear, pH remains stable, and particulates don't form. But binding assays consistently show reduced receptor affinity below therapeutic thresholds. Using degraded peptides in metabolic studies introduces uncontrolled variables that invalidate dose-response data. The cost of replacing the vial is lower than the cost of repeating an entire experiment.

What If My Refrigerator Malfunctioned and Hit 12°C for Six Hours?

Log the incident and mark the vial as compromised. At 12°C, hydrolysis rates triple compared to 4°C storage. Six hours at that temperature reduces potency by approximately 8–15%. If you're running dose-dependent assays where precision matters, that's enough to shift your results. Some labs attempt potency recovery calculations, but those require HPLC verification. And if you have access to HPLC, you're better off reconstituting a fresh vial than trying to adjust for partial degradation.

What If I Reconstituted More Cagrilintide Than I'll Use in 28 Days?

Aliquot it immediately into single-use vials before the first use. Draw the entire reconstituted volume into a sterile syringe, dispense into multiple amber vials (one per dose), and refrigerate them all. This prevents repeated needle punctures through the same stopper, which introduces contaminants and creates pressure differentials that pull air back into the vial. Each aliquot still expires 28 days from the original reconstitution date. Not 28 days from when you opened that specific vial.

What If the Peptide Looks Cloudy After Reconstitution?

Do not use it. Cloudiness indicates protein aggregation. Cagrilintide molecules clumping together instead of remaining in solution. This happens when reconstitution water is too cold, the vial was shaken instead of gently swirled, or the lyophilised powder was exposed to moisture before mixing. Aggregated peptides have near-zero bioactivity. Filtration won't fix it. The molecular structure is already compromised. Reconstitute a new vial using room-temperature bacteriostatic water and gentle swirling only.

The Unflinching Truth About Peptide Stability

Here's the honest answer: most peptide stability failures aren't caused by contamination or poor synthesis. They're caused by researchers underestimating how fragile reconstituted peptides are. Cagrilintide isn't a small molecule. It's a 45-amino-acid chain held together by bonds that break easily under conditions labs tolerate every day.

The pharmaceutical industry treats peptide storage with the same rigour as live cell cultures. Research labs often don't. That's the gap. A lyophilised peptide sitting at −20°C for two years is stable. The same peptide, once reconstituted, degrades measurably within a week if stored incorrectly. And unlike bacterial contamination, which you can see, peptide degradation is invisible until your assay results stop making sense.

If you're running metabolic studies with cagrilintide, the stability window isn't negotiable. Twenty-eight days refrigerated at 2–8°C. No exceptions. No "it's probably fine" guesses. The moment you compromise storage, you're no longer testing cagrilintide. You're testing a degraded peptide mixture with unknown binding properties. That's not research. That's guessing.

Our team has seen labs repeat entire study timelines because they didn't track reconstitution dates. The fix costs nothing. Label vials. Log temperatures. Replace peptides at day 28 even if half the vial remains. The integrity of your data depends on it.

Reconstituted peptides demand the same discipline as any other reagent where molecular structure defines function. Cagrilintide works because its amino-acid sequence folds into a specific shape that fits GIP and GLP-1 receptors. Once that shape degrades, you're injecting inactive protein fragments. The solution might look perfect. It isn't.

If your research timeline requires longer stability windows, work with lyophilised powder and reconstitute smaller volumes more frequently. Single-use aliquots eliminate repeated freeze-thaw risk and reduce contamination from multiple draws through the same stopper. It's more prep work upfront. But it's the difference between data you can publish and data you have to discard.

For researchers working with dual agonists like cagrilintide, proper storage isn't optional. It's the baseline that makes everything else possible. High-purity synthesis matters. Exact amino-acid sequencing matters. But if the peptide degrades in your fridge before you use it, none of that matters. The study fails at the storage stage, not the science stage.